Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-06

Clinical Trial Update: Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars [NA]

View source ↗

Summary

A clinical trial evaluating the efficacy of fractional Er:YAG laser for lupus erythematosus cutaneous scars has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Lupus Erythematosus, Cutaneous | NA | Status: WITHDRAWN